Related Experiment Video
Updated: Feb 10, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3
A Aguirre-Quiñonero1,2, I C Pérez Del Molino3, C García de la Fuente3
1Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Avenida de Valdecilla s/n, 39008, Santander, Spain. amayiaguirre@gmail.com.
Abstract:
The aims of this study were to determine the correlation of mutations in the ftsI gene (coding for PBP3) of Haemophilus influenzae with aminopenicillin resistance and to evaluate the 2017 European Committee for Antibiotic Susceptibility Testing (EUCAST) guidelines for clinical categorization of ampicillin, amoxicillin, and amoxicillin-clavulanate for strains with mutated PBP3 conferring resistance (rPBP3). A panel of 91 H. influenzae isolates was genetically characterized by sequencing of the fstI gene. For all the studied isolates, a screening with benzylpenicillin 1U (BP1) was carried out and minimum inhibitory concentrations (MICs) of ampicillin, amoxicillin, and amoxicillin-clavulanate were tested and interpreted according to EUCAST recommendations. ftsI sequence analysis revealed a total of 14 different amino acid substitutions in PBP3. The substitution patterns most commonly observed were [D350N, M377I, A502V, N526K] among the bla-positive rPBP3 strains (37.5%) and [D350N, A502T, N526K] among the bla-negative rPBP3 strains (24.5%). Screening with BP1 was able to correctly categorize 100% of the bla-negative sPBP3 strains, 100% of the bla-positive strains, and 92% of the bla-negative rPBP3 ones. Only 29% of the bla-negative rPBP3 strains evaluated displayed ampicillin MICs above the current EUCAST resistant breakpoint defined at 1 μg/ml. The PBP3 substitution patterns of the strains evaluated are similar to the ones observed in previous Spanish and European studies. Although the screening with BP1 proved to be adequate in the detection of bla-negative rPBP3 strains, these cannot be reliably identified by current 2018 EUCAST breakpoints for ampicillin.
Insights
Mutations in the ftsI gene (PBP3) of Haemophilus influenzae correlate with aminopenicillin resistance. Current EUCAST guidelines may not reliably identify resistant strains, necessitating improved diagnostic approaches for ampicillin resistance.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Aminopenicillin resistance in Haemophilus influenzae is a growing concern.
- Mutations in the ftsI gene, encoding penicillin-binding protein 3 (PBP3), are a primary mechanism of resistance.
- Accurate susceptibility testing is crucial for effective treatment of H. influenzae infections.
Purpose of the Study:
- To investigate the correlation between ftsI gene mutations and aminopenicillin resistance in H. influenzae.
- To evaluate the performance of current European Committee for Antibiotic Susceptibility Testing (EUCAST) guidelines for categorizing ampicillin, amoxicillin, and amoxicillin-clavulanate resistance.
- To assess the utility of benzylpenicillin screening (BP1) for detecting resistant strains.
Main Methods:
- Genetic characterization of 91 H. influenzae isolates by sequencing the ftsI gene.
- Phenotypic testing including screening with benzylpenicillin 1U (BP1) and determination of minimum inhibitory concentrations (MICs) for ampicillin, amoxicillin, and amoxicillin-clavulanate.
- Interpretation of MICs according to EUCAST recommendations.
Main Results:
- Fourteen distinct amino acid substitutions in PBP3 were identified.
- Common substitution patterns were observed in both bla-positive and bla-negative resistant PBP3 (rPBP3) strains.
- Benzylpenicillin screening (BP1) correctly categorized most strains, but only 29% of bla-negative rPBP3 strains had ampicillin MICs above the EUCAST resistant breakpoint.
- Current EUCAST breakpoints for ampicillin may not reliably identify bla-negative rPBP3 strains.
Conclusions:
- The study confirms the association between ftsI mutations and aminopenicillin resistance in H. influenzae.
- Existing EUCAST breakpoints for ampicillin may underestimate resistance in certain H. influenzae strains with mutated PBP3.
- Further refinement of susceptibility testing guidelines is needed for accurate clinical categorization of ampicillin resistance.
Related Concept Videos
Ligand Binding and Linkage
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The Equilibrium Binding Constant and Binding Strength
Drug Distribution: Plasma Protein Binding
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Single-Strand DNA Binding Proteins

